本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Caris Life Sciences, Inc.

28.01
+1.887.19%
盤後28.280.2700+0.96%19:52 EDT
成交量:682.24萬
成交額:1.88億
市值:79.03億
市盈率:75.30
高:28.32
開:26.19
低:25.77
收:26.13
52周最高:39.30
52周最低:14.19
股本:2.82億
流通股本:1.16億
量比:1.20
換手率:5.88%
股息:- -
股息率:- -
每股收益(TTM):0.3720
每股收益(LYR):-3.2200
淨資產收益率:20.13%
總資產收益率:8.77%
市淨率:13.36
市盈率(LYR):-8.70

資料載入中...

2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/04/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/04

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report